Endometrin effervescent vaginal tablets; Burkholderia contamination
Last updated
Summary
Product
Endometrin effervescent vaginal tablets
Issue
Health products - Contamination
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
Ferring Inc. |
Endometrin effervescent vaginal tablets |
DIN 02334992 |
Vaginal Tablet, Effervescent |
Progesterone 100 mg |
AA207A, AB208A |
Issue
Affected lot(s) may contain the presence of Burkholderia contamination.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Retailers, Healthcare establishments
Details
Original published date: 2023-06-02
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Ferring Inc.
200 Yorkland Blvd., Suite 500,
North York, Ontario, M2J 5C1 Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-73753